Test Price
2,800 AED✅ Home Collection Available
CSTA Gene Peeling Skin Syndrome Type 4 NGS Genetic Test in Dubai, UAE | 2800 AED | DHA Licensed Lab
Executive Summary & Core Metrics
Diagnostic Accuracy Guarantee: 99.9% Sensitivity via ISO 9001:2015 Certified NGS Processing.
Premium Home Collection: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM, daily).
Clinical Guidance: Complimentary Post-Test Telephonic Clinical Guidance by DHA-Licensed Medical Genetics Consultant.
Insurance Direct Billing: Verify coverage via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
The CSTA Gene Peeling Skin Syndrome Type 4 NGS Test uses next-generation sequencing to identify pathogenic variants in the CSTA gene, essential for diagnosing this rare autosomal recessive dermatosis. This test provides comprehensive coverage of the entire gene, including detection of point mutations, small indels, and copy number variants, enabling accurate diagnosis and informed clinical management.
| Feature | Our Test (CSTA NGS) | Alternative Lab Test |
|---|---|---|
| Precision | 99.9% Analytical Sensitivity & Specificity | ~95% (Sanger sequencing misses large deletions) |
| Methodology | Full Gene NGS with Copy Number Variant Detection | Sanger sequencing of selected exons only |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Certification | ISO 9001:2015, DHA-Compliant | May vary |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Reg ID: 9294403: “A positive CSTA mutation confirms Peeling Skin Syndrome Type 4, but clinical correlation is essential — mild phenotypes may need only supportive care, while severe cases require multidisciplinary management. I strongly recommend pre-test genetic counselling to understand potential outcomes and family implications. Never discontinue prescribed medications without consulting your doctor.”
Advisory on Medication Safety
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Abrupt cessation may lead to adverse health outcomes.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Recent blood transfusion (within 14 days) or allogeneic stem cell transplant may interfere with germline DNA interpretation.
Emergency Red Flags
- If skin peeling is accompanied by fever above 38.5°C, severe dehydration, or signs of systemic infection (tachycardia, hypotension), visit the nearest emergency department immediately.
Patient FAQ & Clinical Guidance
1. How accurate is the CSTA gene NGS test for Peeling Skin Syndrome Type 4?
This test delivers 99.9% analytical sensitivity and specificity, ensuring reliable detection of point mutations, small indels, and copy number variants across the entire CSTA gene.
2. What sample is required and is home collection available in the UAE?
We accept blood, extracted DNA, or a single dried blood spot on an FTA card, collected by our ISO-certified VIP mobile phlebotomy team across the UAE. Home collection available daily from 8 AM to 11 PM.
3. Do I need genetic counselling before this test?
Yes, DHA guidelines strongly recommend pre-test genetic counselling to explain the implications and obtain informed consent before proceeding.
UAE Regulatory & Data Privacy Adherence
Your genetic data is handled in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability
All testing is performed under the supervision of the Dubai Health Authority (DHA) and in accordance with ISO 9001:2015 quality standards.
Clinical & Logistical Metadata
| Test Name | CSTA Gene Peeling Skin Syndrome Type 4 NGS Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, Extracted DNA, or Dried Blood Spot on FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with Copy Number Variant Detection |
| ICD-10-CM Code | Q80.8 |
| LOINC Code | 55231-1 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians